Skip Navigation LinksHome > December 2012 - Volume 11 - Issue 4 > Who Do You Think Is in Control in Addiction? A Pilot Study o...
Addictive Disorders & Their Treatment:
doi: 10.1097/ADT.0b013e31823da151
Original Articles

Who Do You Think Is in Control in Addiction? A Pilot Study on Drug-related Locus of Control Beliefs

Ersche, Karen D. PhD*,†; Turton, Abigail J. BSc*,†; Croudace, Tim PhD*; Štochl, Jan PhD*

Open Access
Supplemental Author Material
Collapse Box

Abstract

Objectives: The drug-related locus of control scale (DR-LOC) is a new instrument for assessing a person’s belief of “being in control” in situations involving drug abuse. It consists of 16-item pairs presented in a forced-choice format, based on the conceptual model outlined by Rotter. The model characterizes the extent to which a person believes that the outcome of an event is under their personal control (internal locus of control) or the influence of external circumstances (external locus of control).

Methods: A total of 592 volunteers completed the DR-LOC and the Rotter’s I-E scale. Approximately half of the respondents were enrolled in a drug treatment program for opiates, stimulants and/or alcohol dependence (n=282), and the remainder (n=310) had no history of drug dependence.

Results: Factor analysis of DR-LOC items revealed 2 factors reflecting control beliefs regarding (i) the successful recovery from addiction, and (ii) decisions to use drugs. The extent to which a person attributes control in drug-related situations is significantly influenced by their personal or professional experiences with drug addiction. Drug-dependent individuals have a greater internal sense of control with regard to addiction recovery or drug-taking behaviors than health professionals and/or non-dependent control volunteers.

Conclusions: The DR-LOC has shown to effectively translate generalized expectancies of control into a measure of control expectancies for drug-related situations, making it more sensitive for drug-dependent individuals than Rotter’s I-E scale. Further research is needed to demonstrate its performance at discriminating between heterogeneous clinical groups such as between treatment-seeking versus non–treatment-seeking drug users.

© 2012 Lippincott Williams & Wilkins, Inc.

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.